13908-00-4 Usage
Uses
Used in Pharmaceutical Industry:
1-(2-chloroethyl)-3-(2,2,2-trifluoroethyl)urea serves as a crucial building block or intermediate in the production of various pharmaceuticals. Its distinct structural attributes and reactivity enable the creation of new molecules with possible biological activity, thereby contributing to the development of novel drugs.
Used in Agrochemical Industry:
Similarly, in the agrochemical sector, 1-(2-chloroethyl)-3-(2,2,2-trifluoroethyl)urea acts as an essential intermediate. It aids in the synthesis of different agrochemicals, potentially enhancing crop protection and management strategies.
Used in Drug Delivery Systems:
1-(2-chloroethyl)-3-(2,2,2-trifluoroethyl)urea's structure, which includes a chloroethyl and a trifluoroethyl group, suggests its utility in drug delivery systems. It may facilitate targeted therapy by enhancing the compound's ability to reach specific sites within the body, thereby improving treatment efficacy and reducing side effects.
Used in Organic Synthesis:
1-(2-chloroethyl)-3-(2,2,2-trifluoroethyl)urea is also utilized as a vital component in organic synthesis. Its unique reactivity allows for the creation of a wide range of chemical products, contributing to the diversity and innovation within the chemical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 13908-00-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,9,0 and 8 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 13908-00:
(7*1)+(6*3)+(5*9)+(4*0)+(3*8)+(2*0)+(1*0)=94
94 % 10 = 4
So 13908-00-4 is a valid CAS Registry Number.
13908-00-4Relevant academic research and scientific papers
PYRAZOLO[1,5-A]PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
-
Paragraph 00652, (2017/11/06)
The invention provides substituted pyrazolo[1,5-a]pyrimidinyl carboxamide and related organic compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat medical disorders, e.g., Gaucher disease, Parkinson's disease, Lewy body disease, dementia, or multiple system atrophy, in a patient. Exemplary substituted pyrazolo[1,5-a]pyrimidinyl carboxamide compounds described herein include 2-heterocyclyl-4-alkyl-pyrazolo[1,5-a]pyrirnidine-3-carboxarnide compounds and variants thereof.
IMIDAZOLIDINONES AND ANALOGS EXHIBITING ANTI-CANCER AND ANTI-PROLIFERATIVE ACTIVITIES
-
Paragraph 0368, (2014/10/29)
Described are compounds of Formula I which find utility in the treatment of cancer, autoimmune diseases and metabolic bone disorders through inhibition of c-FMS (CSF-1R), c-KIT, and/or PDGFR kinases. These compounds also find utility in the treatment of other mammalian diseases mediated by c-FMS, c-KIT, or PDGFR kinases.
